Family Medicine · Cerritos, CA
NPI
1932113313
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
11841 South St
Cerritos, CA, 90703
Phone (562) 809-8082
Groups this clinician bills Medicare through
Medicare paid, 2024
$242K
7,923 services
Medicare patients, 2024
457
Average age 79
Drug cost, 2024
$2.1M
6,465 prescriptions
Company payments, 2025
$1,986
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yoon S Pak was code 99212 (office e&m - established), 2,399 times for 429 patients. In total Yoon S Pak billed 7,923 services in 31 codes, and Medicare paid $242K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 2,399 | 429 | $45.35 | $109K |
| 96372 Injection Administration | Office | 1,454 | 254 | $11.89 | $17K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,188 | 101 | $0.08 | $100 |
| 82962 Clinical Chemistry | Office | 757 | 169 | $3.21 | $2,430 |
| 36415 Venipuncture Blood Collection | Office | 395 | 254 | $8.65 | $3,417 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 181 | 172 | $103.87 | $19K |
| 96361 Intravenous Infusion, Hydration | Office | 176 | 32 | $10.03 | $1,766 |
| J2920 Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 175 | 71 | $2.80 | $490 |
| 76536 Ultrasound - Nonspecific | Office | 168 | 160 | $98.76 | $17K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 159 | 154 | $170.29 | $27K |
| 93306 Echocardiography (TTE/TEE) | Office | 144 | 141 | $175.78 | $25K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 97 | 94 | $59.39 | $5,761 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 96 | 66 | $0.32 | $30.77 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 94 | 45 | $0.45 | $42.7 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 69 | 50 | $0.94 | $65.14 |
By year: 2022 $255K for 6,622 services; 2023 $281K for 7,573 services; 2024 $242K for 7,923 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 757 | 169 | $3.21 | $2,430 |
| 36415 Venipuncture Blood Collection | 395 | 254 | $8.65 | $3,417 |
| 81002 Clinical Chemistry | 49 | 40 | $3.41 | $167 |
Medicare prescription drug claims, 2024
In 2024, the drug Yoon S Pak prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 308 prescriptions and refills. In total Yoon S Pak wrote 6,465 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 308 | 378 | 46 | $129K |
| Amlodipine Besylate Generic | 267 | 512 | 54 | $689 |
| Farxiga Dapagliflozin Propanediol | 262 | 345 | 42 | $194K |
| Losartan Potassium Generic | 230 | 371 | 39 | $770 |
| Olmesartan Medoxomil Generic | 204 | 355 | 39 | $1,743 |
| Pantoprazole Sodium Generic | 188 | 265 | 54 | $809 |
| Creon Lipase/Protease/Amylase | 171 | 196 | 37 | $317K |
| Kerendia Finerenone | 171 | 248 | 29 | $158K |
| Repatha Sureclick Evolocumab | 165 | 189 | 29 | $101K |
| Atorvastatin Calcium Generic | 163 | 276 | 34 | $568 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 149 | 176 | 31 | $110K |
| Rosuvastatin Calcium Generic | 136 | 267 | 35 | $977 |
| Metformin Hcl Generic | 134 | 235 | 27 | $367 |
| Repatha Pushtronex Evolocumab | 132 | 176 | 31 | $102K |
| Clopidogrel Clopidogrel Bisulfate | 131 | 208 | 23 | $552 |
Brand drugs: - claims; generic drugs: 3,847 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yoon S Pak $1,986 ($1,986 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $317.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $317 |
| Ardelyx, Inc. ARDX | 13 | $286 |
| Aimmune Therapeutics, Inc. | 19 | $280 |
| Abbvie Inc. ABBV | 16 | $279 |
| IBSA Pharma Inc. | 19 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $168 |
| Novo Nordisk Inc NVO | 4 | $72.03 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66.8 |
| Radius Health, Inc. | 2 | $56.79 |
| QOL Medical, LLC | 2 | $56.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.